Stay updated with breaking news from Peter Garnry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Many policymakers have recently topped up asset-purchase schemes, so that the crowding-out of private investors from public bond markets looks set to continue., , global stocks, policymakers, jpmorgan
* U.S. stock futures up 0.25% * Sterling up 0.5% vs dollar LONDON, Dec 23 (Reuters) - Stocks rose on Wednesday as a last-minute intervention by U.S. President Donald Trump over pandemic relief plans failed to wipe out positive sentiment, while the pound gained on the possibility of a Brexit trade deal. In a video posted on Twitter, Trump said a stimulus bill, agreed after months of wrangling in Congress, was “a disgrace” and that he wanted to increase “ridiculously low” $600 checks for individuals to $2,000. The possibility of a delay to long-awaited and hard-fought spending plans sen...
Supply squeeze won't ease on global stocks and bonds in 2021 Toggle share menu Advertisement Supply squeeze won't ease on global stocks and bonds in 2021 Bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019. (Photo: REUTERS/Kai Pfaffenbach) 24 Dec 2020 01:10AM (Updated: 24 Dec 2020 02:41AM) Share this content Bookmark LONDON: An unrelenting squeeze on the supply of global shares and sovereign bonds shows little sign of easing next year, with companies and central banks predicted to be big buyers of these secu...
Analysis-Supply squeeze won't ease on global stocks and bonds in 2021 Sujata Rao , By Sujata Rao LONDON (Reuters) - An unrelenting squeeze on the supply of global shares and sovereign bonds shows little sign of easing next year, with companies and central banks predicted to be big buyers of these securities in direct competition with investors. The supply mismatch could help to sustain the decade-long bull run in global equities and also keep bond yields at very low levels. A string of high-profile intial public offerings, as well as emergency secondary l...
Provided by Dow Jones By Caitlin Ostroff and Caitlin McCabe The Dow Jones Industrial Average tumbled Tuesday as concerns about elevated Covid-19 infection levels and a new strain of the virus in Europe overshadowed Congress' approval of a Covid-19 relief package. The index of blue-chip stocks fell 200.94 points, or 0.7%, to 30015.51, marking its largest one-day point and percentage decline in December. The S&P 500 slid 7.66 points, or 0.2%, to 3687.26 to extend its losing streak to a third session. The tech-heavy Nasdaq Composite, in contrast, rose 65.40 p...